| CNTX Market Cap History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the CNTX market cap history going back to 10/20/2021:
Also see: CNTX Shares Outstanding History and CNTX YTD Return |
CNTX Market Cap History — Context Therapeutics Capitalization Over Time
As of 5/4/2026 Context Therapeutics has a market cap of 211.32 million. Investors often follow the CNTX market cap history to compare the size of the company over time.
This page shows CNTX market capitalization trends over time, with 16 market cap datapoints presented, dating back to 10/20/2021.
| CNTX Market Cap History Chart | |||||||||||||||||||||||||||||||||||
CNTX Historical Market Cap: +36.15% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||
| CNTX Stock Price Chart |
| About Context Therapeutics Inc |
| Centrexion Therapeutics Corp is a late clinical-stage biopharmaceutical company. Co. is focused on identifying, developing and commercializing therapies to address the unmet medical need for the treatment of chronic pain. Its product candidate pipeline includes CNTX-4957, CNTX-0290, CNTX-6970, CNTX-2022 and CNTX-6016. Its product candidates are designed to treat pain conditions of multiple etiologies associated with a wide variety of common disease states. CNTX-4975 is designed to target and disrupt the signaling of pain-sensing nerve fibers. CNTX-0290 product candidate is an investigational small molecule SSTR4 agonist. CNTX-6970 is a potent and selective investigational CCR2 antagonist. We show 16 historical shares outstanding datapoints in our CNTX shares outstanding history coverage, used to compute CNTX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CNTX market cap history over the course of time is important for investors interested in comparing CNTX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CNTX versus a peer is one thing; comparing CNTX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CNTX can fluctuate over the course of history. With this page we aim to empower investors researching CNTX by allowing them to research the CNTX market cap history. |
| CNTX Current Stock Quote |
Quotes delayed 20 minutes  Free CNTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CNTX Share Performance |
| Market Cap Peers |
| Context Therapeutics (CNTX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CNVY Market Cap History COCP Market Cap History CODX Market Cap History COGT Market Cap History COLL Market Cap History COM Market Cap History CON Market Cap History COO Market Cap History COOL Market Cap History COR Market Cap History More Healthcare companies » |
CNTX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
